We are live on
!
Find out more
First Eagle Investment Management Portfolio holdings
AUM
$59B
1-Year Est. Return
32.99%
This Fund
S&P 500
This Quarter
Est. Return
+0.3%
1 Year Est. Return
+32.99%
3 Year Est. Return
+85.58%
5 Year Est. Return
+122.56%
10 Year Est. Return
+357.65%
AUM
$32.9B
AUM Growth
–
Cap. Flow
+$33.3B
Cap. Flow
% of AUM
101.16%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
353
New
351
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Microsoft
MSFT
|
+$985M |
| 2 |
Cisco
CSCO
|
+$970M |
| 3 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$968M |
| 4 |
GG
Goldcorp Inc
GG
|
+$897M |
| 5 |
Sysco
SYY
|
+$856M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 15.7% |
| 2 | Materials | 14.84% |
| 3 | Financials | 13.86% |
| 4 | Energy | 10.62% |
| 5 | Industrials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Xylem
XYL
$28.9B
| $1.7M | 0.01% |
+63,000
| New | +$1.74M |
|
|
STRZA
227
DELISTED
Starz - Series A
STRZA
| $1.62M | ﹤0.01% |
+73,355
| New | +$1.65M |
|
|
PBTH
228
DELISTED
PROLOR Biotech, Inc. Common Stock
PBTH
| $1.51M | ﹤0.01% |
+240,430
| New | +$1.44M |
|
229
Iron Mountain
IRM
$36.5B
| $1.33M | ﹤0.01% |
+54,100
| New | +$1.75M |
|
|
ACGN
230
DELISTED
Aceragen Inc
ACGN
| $1.31M | ﹤0.01% |
+14,721
| New | +$1.33M |
|
|
ONCY
231
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
| $1.3M | ﹤0.01% |
+450,000
| New | +$1.24M |
|
|
ELRC
232
DELISTED
ELECTRO RENT CORP
ELRC
| $1.2M | ﹤0.01% |
+71,600
| New | +$1.22M |
|
|
TWX
233
DELISTED
Time Warner Inc
TWX
| $1.2M | ﹤0.01% |
+21,666
| New | +$1.23M |
|
|
DELL
234
DELISTED
DELL INC
DELL
| $1.16M | ﹤0.01% |
+87,100
| New | +$1.18M |
|
|
AMIC
235
DELISTED
AMERICAN INDEPENDENCE CORP
AMIC
| $1.16M | ﹤0.01% |
+166,574
| New | +$1.21M |
|
|
LXK
236
DELISTED
Lexmark Intl Inc
LXK
| $1.13M | ﹤0.01% |
+37,100
| New | +$1.09M |
|
237
HSBC
HSBC
$340B
| $1.11M | ﹤0.01% |
+24,859
| New | +$1.16M |
|
|
MTEM
238
DELISTED
Molecular Templates, Inc.
MTEM
| $1.05M | ﹤0.01% |
+1,212
| New | +$1.02M |
|
239
ResMed
RMD
$28B
| $993K | ﹤0.01% |
+22,000
| New | +$1.04M |
|
240
O-I Glass
OI
$1.3B
| $934K | ﹤0.01% |
+33,600
| New | +$907K |
|
241
Novartis
NVS
$287B
| $923K | ﹤0.01% |
+14,575
| New | +$948K |
|
242
Monster Beverage
MNST
$95.8B
| $912K | ﹤0.01% |
+90,000
| New | +$845K |
|
243
ITT
ITT
$17.4B
| $907K | ﹤0.01% |
+30,850
| New | +$888K |
|
244
AptarGroup
ATR
$8.19B
| $862K | ﹤0.01% |
+15,619
| New | +$879K |
|
245
Comcast
CMCSA
$82.8B
| $838K | ﹤0.01% |
+40,000
| New | +$826K |
|
|
FOE
246
DELISTED
Ferro Corporation
FOE
| $834K | ﹤0.01% |
+120,000
| New | +$833K |
|
|
CEQP
247
DELISTED
Crestwood Equity Partners LP
CEQP
| $801K | ﹤0.01% |
+5,000
| New | +$685K |
|
|
LTRE
248
DELISTED
LEARNING TREE INTL INC
LTRE
| $776K | ﹤0.01% |
+254,283
| New | +$894K |
|
249
Manhattan Associates
MANH
$9.38B
| $772K | ﹤0.01% |
+40,000
| New | +$733K |
|
250
MetLife
MET
$59.5B
| $769K | ﹤0.01% |
+18,850
| New | +$693K |
|
Similar funds
NAMI
QCM
